# A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT

> **NCT02010203** · PHASE1,PHASE2 · TERMINATED · sponsor: **Heat Biologics** · enrollment: 104 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **BIOLOGICAL:** HS-410
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** BCG

## Key facts

- **NCT ID:** NCT02010203
- **Lead sponsor:** Heat Biologics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12
- **Primary completion:** 2017-12
- **Final completion:** 2018-04
- **Target enrollment:** 104 (ACTUAL)
- **Why stopped:** Inability to accrue due to changing treatment landscape (PD-1 approvals)
- **Last updated:** 2020-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02010203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02010203, "A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02010203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*